Content matching 'Investigational New Drug'
Research by Douglas Melton of Harvard University and colleagues showing that insulin-producing pancreatic beta cells can be created in a laboratory has reached the stage of commercialisation with the launch of a new company aimed at bringing a cell therapy for diabetes into human trials.
Regional diffusion gradients of molecular factors provide developmental cues in neural tissue organoids
Reducing stem cell variability with automation for standardized treatments: an interview with NYSCF's Scott Noggle
The Netherlands-based cell therapy company Kiadis Pharma BV is planning an initial public offering (IPO) of its shares on the Euronext stock exchanges in Amsterdam and Brussels to finance the clinical development of a cell therapy that helps reconstitute the immune system after a bone marrow transplant.